UNITED STATES OF AMERICA —Private equity firm KKR has finalized its acquisition of medical technology manufacturer Integer Holdings Corporation at an enterprise value of approximately $5.7 billion. Under the terms of the finalized transaction, equity holders received $127 per share in cash. Following the completion of the buyout, common shares of the target enterprise ceased trading and were delisted from the New York Stock Exchange.
Integer Holdings Corporation is a major medical device contract development and manufacturing organization that serves global markets including cardio and vascular, neuromodulation, and cardiac rhythm management. Headquartered in Plano, Texas, the organization operates under prominent industry brands such as Greatbatch Medical and Lake Region Medical. KKR is a global investment firm offering alternative asset management, capital markets, and insurance solutions across international markets.
This corporate buyout represents a major strategic shift for the contract manufacturing sector within the medical technology ecosystem. By transitioning into a privately held entity backed by private equity resources, the firm gains structural flexibility to pursue long-term capital allocation strategies, fund advanced engineering capabilities, and expand operational infrastructure without the immediate scrutiny of public market reporting requirements.
The transaction directly impacts medical device developers, institutional investors, and global healthcare supply chains. Equipment innovators relying on outsourced engineering and component production will monitor how private equity ownership influences production scaling and technological investment. Furthermore, the transaction underscores ongoing private equity interest in high-margin medical manufacturing assets that exhibit stable demand fundamentals driven by global healthcare needs.